The discrepancy could be due to population variations in competing risk factors such as genetic burden (e.g., BRCA1/2 mutations), hormone replacement therapy, and obesity, as well as protective factors such as multiple pregnancies and breastfeeding. This evidence concerns the gene BRCA1 and obesity due to melanocortin 4 receptor deficiency.